E
SYRS

Ergoteles’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Ergoteles’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,181
Closed -$65.3K – 1848
2022
Q4 		$65.3K Buy
+18,181
New +$65.3K ﹤0.01% 1268
2022
Q3 		– Sell
-26,940
Closed -$259K – 2076
2022
Q2 		$259K Buy
+26,940
New +$259K 0.01% 1189